Literature DB >> 12213052

Pyrimidinylpyrroloquinolones as highly potent and selective PDE5 inhibitors for treatment of erectile dysfunction.

Zhihua Sui1, Jihua Guan, Mark J Macielag, Weiqin Jiang, Suying Zhang, Yuhong Qiu, Patricia Kraft, Sheela Bhattacharjee, T Matthew John, Donna Haynes-Johnson, Joanna Clancy.   

Abstract

A series of N-pyrimidinylpyrroloquinolones were discovered as extremely potent and selective PDE5 inhibitors. Representative compounds demonstrated in vivo efficacy in dog erectile dysfunction models and are orally bioavailable.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12213052     DOI: 10.1021/jm025545d

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  1 in total

1.  Mild and efficient Winterfeldt oxidation of 1,2,3,4-tetrahydro-γ-carbolines for the synthesis of dihydropyrrolo[3,2-b]-quinolones and pyrrolo[3,2-b]quinolones.

Authors:  Rong Sheng; Jiangwei Zhu; Yongzhou Hu
Journal:  Molecules       Date:  2012-01-30       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.